These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7689507)
1. High detection rate of hepatitis C virus E2 antibody in patients with type C hepatitis. Yokosuka O; Ito Y; Ohto M; Omata M Gastroenterol Jpn; 1993 May; 28 Suppl 5():52-4. PubMed ID: 7689507 [TBL] [Abstract][Full Text] [Related]
2. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis. Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430 [TBL] [Abstract][Full Text] [Related]
3. Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease. Yokosuka O; Omata M; Ito Y; Ohto M Gut; 1993; 34(2 Suppl):S64-5. PubMed ID: 7686121 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia. Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of type C fulminant hepatitis by the detection of antibodies to the putative core proteins of hepatitis C virus. Yoshiba M; Sekiyama K; Sugata F; Okamoto H Gastroenterol Jpn; 1991 Apr; 26(2):234. PubMed ID: 1645689 [No Abstract] [Full Text] [Related]
6. Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein. Detection of anti-hepatitis C core antibody by western blot. Yokosuka O; Ito Y; Sakuma J; Imazeki F; Ohto M; Omata M Dig Dis Sci; 1993 Apr; 38(4):626-30. PubMed ID: 7681745 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope. Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249 [TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of the antibody against core protein of hepatitis C virus. Ohkoshi S; Watanabe M; Kuwana K; Tawaraya H; Kamimura T; Asakura H Gastroenterol Jpn; 1993 May; 28 Suppl 5():80-3. PubMed ID: 7689513 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma. Watanabe Y; Harada S; Saito I; Miyamura T Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205 [TBL] [Abstract][Full Text] [Related]
10. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV. León P; López JA; Elola C; Domingo CJ; Echevarria JM Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926 [TBL] [Abstract][Full Text] [Related]
11. Detection by western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease. Hada H; Koide N; Hanafusa T; Sakaguchi K; Shinji T; Sasaki S; Oka T; Takayama N; Yumoto Y; Tsuji T Acta Med Okayama; 1992 Oct; 46(5):365-70. PubMed ID: 1279946 [TBL] [Abstract][Full Text] [Related]
12. Anti-HCV immunoglobulin M antibody in patients with acute and fulminant hepatitis C. Akbar SM; Onji M; Horiike N; Ohta Y Gastroenterol Jpn; 1993 May; 28 Suppl 5():71-5. PubMed ID: 7689511 [TBL] [Abstract][Full Text] [Related]
13. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein]. Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883 [TBL] [Abstract][Full Text] [Related]
14. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus. Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to hepatitis C virus and hepatitis C virus infection. Yuki N; Hayashi N; Kasahara A; Hagiwara H; Fusamoto H; Kamada T Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512 [TBL] [Abstract][Full Text] [Related]
16. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine. Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595 [TBL] [Abstract][Full Text] [Related]
17. Antibody to hepatitis C virus in cryptogenic chronic liver disease. Diodati G; Tagger A; Bonetti P; Ribero ML; Drago C; Cavalletto D; Grossi A; Realdi G; Ruol A; Alberti A J Med Virol; 1991 Nov; 35(3):151-4. PubMed ID: 1725178 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368 [TBL] [Abstract][Full Text] [Related]
19. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831 [TBL] [Abstract][Full Text] [Related]
20. IgM anti-C100-3 antibodies in hepatitis C virus infection. Sansonno D; Gatti P Int J Clin Lab Res; 1992; 21(3):267-8. PubMed ID: 1317226 [No Abstract] [Full Text] [Related] [Next] [New Search]